Trial Profile
A Study to Evaluate the Short-term Safety and Tolerability of Teriflunomide in Patients with Relapsing Remitting Multiple Sclerosis (RRMS)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 19 Dec 2015 New trial record